A novel compound sciryagarol II having antineoplastic and antibiosis activities and a preparation method thereof

A compound and anti-tumor technology, applied in the field of medicine, can solve the problems of unreported cis-stilbene compounds and the like

Inactive Publication Date: 2013-10-02
NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the stilbenes isolated from Vitexiaceae include trans-stilbene compounds: resveratrol, piceatann

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A novel compound sciryagarol II having antineoplastic and antibiosis activities and a preparation method thereof
  • A novel compound sciryagarol II having antineoplastic and antibiosis activities and a preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] The preparation method of embodiment 1 trigonol II

[0013] Take 20Kg of dried tubers of Scirpus yagara purchased from Zhejiang, crush them, heat and reflux them with 80% ethanol aqueous solution for extraction three times, combine the three extracts, concentrate under reduced pressure until there is no alcohol smell, dilute the concentrate with water to form a suspension, and separate With petroleum ether, ethyl acetate extraction. The ethyl acetate extracts were combined and concentrated to obtain 60.9 g of extract, and the extract was subjected to silica gel column (200-300 mesh) chromatography, with petroleum ether: ethyl acetate gradient (100:0, 100:2, 100:4, ... ..., 100:20) elution, GF254 silica gel thin-layer chromatography, ultraviolet inspection, collect the fraction containing cinnamonol II, combine and concentrate and then go through silica gel column chromatography, and use petroleum ether-ethyl acetate gradient (100:5 , 100:7, 100:9,..., 100:15) elution, ...

Embodiment 2

[0014] Example 2 Inhibitory effect of tricerol II on human cervical cancer Hela cells, human liver cancer SMMC-7721 cells and human gastric cancer MGC-803 cells

[0015] Hela cells (3×10 4 cells / mL), SMMC-7721 and MGC-803 cells (5×10 4 cells / mL), were inoculated on a 96-well plate at 100 uL per well, and 4 duplicate wells were set up. Hela cells were cultured for 10 hours, and the culture medium was discarded. After SMMC-7721 and MGC-803 cells were cultured for 20 hours, the culture medium was discarded, and then the medium was discarded. Add 100uL / well of each drug at different concentrations, the highest concentration of each drug is 100uM / L, 10 times the dose interval, set five doses, and each dose has four replicate wells. Add 100uL DMSO with a final concentration of 0.1% to the negative control group, add 100uL monoculture to the blank group, culture Hela cells for 36 hours, and culture SMMC-7721 and MGC-803 for 24 hours, add 20 μL of MTT solution with a concentration of...

Embodiment 3

[0016] The inhibitory effect of embodiment 3 trichosanol II on Staphylococcus aureus, Escherichia coli and Candida albicans

[0017] Take a few standard strains: Staphylococcus aureus (ATCC25923) and Escherichia coli (441490) strains, inoculate them in nutrient broth medium respectively, and incubate at 37°C for 18h. Get each bacterial strain nutrient broth culture culture of 18h cultivation, make 10 with nutrient broth -3 diluted for experiments. Take a little strain of Candida albicans, inoculate it in modified Martin's medium, and culture it at 35°C for 24h. Take the culture of Candida albicans cultivated for 24h, and use the modified Martin's medium 10 -3diluted for experiments. Prepare the sample with the double dilution method (test tube method), that is, the initial concentration of the test drug cinnamonol II is 10mg / ml, take 0.1ml and add 5.9ml nutrient broth to dilute and filter for later use, take 8 sterilized test tubes, the first Add 1ml of the test drug dilut...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a novel compound sciryagarol II having antineoplastic and antibiosis activities and a preparation method thereof, and belongs to the field of medicine technology. The sciryagarol II is a novel cis-form stilbene derivative with a structure formula shown below. The sciryagarol II can be prepared from dry tubers of scirpus yagara by extraction. The preparation method comprises steps of extracting with ethanol having a concentration of 80%; condensing under reduced pressure; extracting with petroleum ether and ethyl acetate individually; purifying the ethyl acetate extract by repeatedly performing column chromatography using silica gel; and performing gradient elution by using petroleum ether and ethyl acetate to obtain pure sciryagarol II. The sciryagarol II has good antineoplastic and antibiosis effects, has an IC[50] value of 7.218 [mu]M for human cervical cancer Hela cells, and has a MIC value of 79.3 [mu]g/mL for staphylococcus aureus and candida albicans individually.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a new stilbene compound sciryagarol II isolated from Vitex trigonum and having antitumor and antibacterial activities and a preparation method of the compound. Background technique [0002] Scirpusyagara Ohwi (S.maritimus or S.fluviatilis (Torr.)) is a plant of the genus Cyperaceae, which mostly grows in ponds and ditches, and is mainly produced in the provinces of Northeast China, Jiangsu, Zhejiang, Guizhou, and Taiwan. , In addition, North Korea and Japan are also distributed. Jing San Leng has been used as a San Leng variety for more than a thousand years, and its dried tubers were used as a traditional Chinese medicine San Leng in the Tang Dynasty. It is the earliest variety of San Leng used. Sanleng is flat in nature, bitter in taste, enters the liver and spleen meridians, has the functions of dispelling blood and promoting qi, eliminating stagnation and relieving pain, an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D313/20A61P35/00A61P31/04A61P31/10
Inventor 梁侨丽李军雷玲玲邹娜姝俞晶华吴启南
Owner NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap